WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003018624) VECTORS, CONSTRUCTS, AND TRANSGENIC PLANTS FOR HPV-11 AND HPV-16 L1 CAPSID PROTEIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/018624    International Application No.:    PCT/IB2002/003532
Publication Date: 06.03.2003 International Filing Date: 30.08.2002
Chapter 2 Demand Filed:    28.03.2003    
IPC:
C07K 14/025 (2006.01), C12N 15/82 (2006.01)
Applicants: UNIVERSITY OF CAPE TOWN [ZA/ZA]; Department of Innovation, The Cottage, Rondebosch, 7701 CAPE TOWN (ZA) (For All Designated States Except US).
VARSANI, Arvind, Devshi [KE/ZA]; (ZA) (For US Only).
RYBICKI, Edward, Peter [ZA/ZA]; (ZA) (For US Only).
WILLIAMSON, Anna-Lise [ZA/ZA]; (ZA) (For US Only)
Inventors: VARSANI, Arvind, Devshi; (ZA).
RYBICKI, Edward, Peter; (ZA).
WILLIAMSON, Anna-Lise; (ZA)
Agent: KEMP, Mark; Spoor and Fisher, PO Box 41312, 2024 Craighall (ZA)
Priority Data:
2001/7226 31.08.2001 ZA
Title (EN) VECTORS, CONSTRUCTS, AND TRANSGENIC PLANTS FOR HPV-11 AND HPV-16 L1 CAPSID PROTEIN
(FR) VECTEURS, PRODUITS DE SYNTHESE ET PLANTES TRANSGENIQUES POUR PROTEINE CAPSIDE DU HPV-11 ET DU HPV-16
Abstract: front page image
(EN)Vectors and/or constructs of human papillomavirus genes are used in transforming host cells, such as bacteria, yeast cells, fungal cells, insect cells, mammalian cells and plant cells. The host cells are cultivated under conditions which permit spotaeousamly of at least one protein fragment of a protein encoded by the vector and/or gene construct into an immunogenic-response elicitig virus-like particle directed against human papillomavirus.
(FR)L'invention concerne des vecteurs et/ou des produits de synthèse de gènes du papillomavirus humain utilisés dans des cellules hôtes de transformation, telles que des bactéries, des cellules de levure, des cellules fongiques, des cellules d'insectes, des cellules mammaliennes et des cellules végétales. Les cellules hôtes sont mises en culture dans des conditions permettant un assemblage spontané d'au moins une protéine ou d'un fragment de protéine codé(e) par le vecteur et/ou le produit de synthèse génique dans une réponse immunogénique induisant une particule semblable au virus, dirigée à l'encontre du papillomavirus humain.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)